James R. Kasinger Crispr Therapeutics Ag (CRSP) insider trading activity
James R. Kasinger is General Counsel and Secretary of CRISPR Therapeutics AG. Currently has a direct ownership of 78,664 shares of CRSP, which is worth approximately $3.3 Million. The most recent transaction as insider was on Mar 12, 2025, when has been sold 1,116 shares (Common Shares) at a price of $43.32 per share, resulting in proceeds of $48,345. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
78.7K
25.67%
3M change
28.59%
12M change
Total Value Held
$3.3 Million
JAMES R. KASINGER Transaction History
JRK
James R. Kasinger
General Counsel and Secretary
Cambridge, MA